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Relative expression quantitative real-time polymerase chain reaction (RT-qPCR) 
experiments are a common means of estimating transcript abundances across biological 
groups and experimental treatments. One of the most frequently used expression 
measures that results from such experiments is the relative expression ratio (RE), which 
describes expression in experimental samples (i.e., RNA isolated from organisms, 
tissues, and/or cells that were exposed to one or more experimental or nonbaseline 
condition) in terms of fold change relative to calibrator samples (i.e., RNA isolated from 
organisms, tissues, and/or cells that were exposed to a control or baseline condition). 
Over the past decade, several models of RE have been proposed, and it is now clear that 
endogenous reference gene stability and amplification efficiency must be assessed in 
order to ensure that estimates of RE are valid. In this review, we summarize key issues 
associated with estimating RE from cycle threshold data. In addition, we describe several 
methods based on linear modeling that enable researchers to estimate model parameters 
and conduct quality control procedures that assess whether model assumptions have 
been violated.  
KEYWORDS: amplification efficiency, endogenous reference gene, gene expression, linear 
regression, real-time quantitative reverse transcription PCR, relative expression ratio 
 
INTRODUCTION 
Overview 
Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is a method of 
quantifying transcript abundances that is routinely used to investigate expression in a small to moderate 
number of genes. In particular, RT-qPCR is frequently used to confirm microarray results and to 
investigate the expression of rare transcripts[1,2,3,4,5,6]. The primary strength of RT-qPCR is that its 
large dynamic range makes it well suited for quantifying low abundance transcripts and transcripts that 
vary widely in abundance between groups of interest[7,8,9]. Nevertheless, there are a number of 
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difficulties associated with generating high-quality RT-qPCR data. Previous reviews have described many 
of these issues, including ensuring that RNA is of a sufficient quality and purity[10,11], the pros and cons 
of various approaches to generating cDNA via reverse transcription[7,10,12,13], the importance of proper 
sample storage[11], the need for careful primer design and assay validation[11], and the advantages and 
drawbacks to different detection chemistries[6,10,14,15]. However, comparatively little effort has been 
spent reviewing the issues associated with analysis and quality control of RT-qPCR data.  
Over the past decade, a number of statistical and computational approaches to analyzing RT-qPCR 
data have been suggested in the literature, and it is now clear that applying objective statistical methods to 
RT-qPCR data poses several challenges[8,9,16,17,18]. In this review, we briefly describe the numerical 
data generated via most relative expression RT-qPCR experiments and then discuss several practical 
issues that researchers conducting relative expression RT-qPCR experiments are likely to face. In 
particular, we focus on using linear models for parameter estimation and the evaluation of assumptions 
that are inherent to the calculation relative expression ratios (RE). We then conclude by summarizing the 
steps involved in processing relative expression RT-qPCR data, briefly discussing the issue of error 
propagation – how uncertainty in the parameters used to calculate RE affects the uncertainty of RE itself – 
and listing a set of general guidelines for the quality control and analysis of RE values.  
The Quantification Cycle: The Central Value of RT-qPCR 
The basic strategy underlying RT-qPCR is to record the accumulation of fluorescent dyes that label a 
specific nucleic acid product or double-stranded DNA molecule throughout the course of a PCR. The 
amount of product yielded by a PCR approximates a logistic (i.e., sigmoidal) curve when it is plotted as a 
function of the number of reaction cycles completed (Fig. 1). Thus, setting a threshold within the 
exponential phase of the amplification curve and recording the number of fractional cycles required to 
eclipse this threshold provides a correlate to the initial amount of template known as the quantification 
cycle (Cq; lower Cq values correspond to more starting template). However, while Cq is the value of 
interest in the majority of RT-qPCR experiments, its determination requires exclusion of ground phase 
cycles (Fig. 1; also known as the background or baseline) and determination of where along the y-axis, 
within the exponential phase, the threshold should be placed. Determination of the baseline and threshold 
is usually handled by proprietary software that comes with real-time PCR hardware, and different systems 
use different methods for baseline and threshold determination. Because this review focuses on how to 
analyze Cq values rather than how to ensure they are valid, we do not discuss baseline and threshold 
determination further and refer interested readers to Bustin and Nolan[10] and Adams[19] for discussions 
of when to adjust the baseline and threshold manually. 
The Relative Expression Quantification Strategy 
There are two general approaches to conducting RT-qPCR experiments. The first, known as absolute 
quantification, is based on calibration to a standard curve generated from a known external source (e.g., 
recombinant DNA) that enables one to express data in terms of transcripts per biological unit (e.g., 
copies/μg of tissue). The second, known as relative quantification, describes expression in arbitrary units 
that are based on comparisons to a calibrator sample or a series of calibrator samples (e.g., RNA isolated 
from control or unmanipulated sources). Because the relative quantification approach makes fewer 
assumptions, is less labor intensive, and is sufficient for most applications, it is the method most 
frequently used in basic research and is thus the focus of this review.  
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FIGURE 1. An example of a RT-qPCR amplification plot showing the four 
phases of a PCR. Dashed lines denote the approximate boundaries of each 
phase. The exponential phase is highlighted in gray. Note that the bottom dashed 
horizontal line corresponds to the ground phase.  
The traditional approach to relative expression RT-qPCR is to plug the relevant Cq values, or their 
averages, into one of a number of mathematical models that generate a RE describing expression in 
noncalibrator samples in terms of fold change relative to calibrator samples[8]. Usually, RE is normalized 
to one or more endogenous reference genes (ERGs)[8] because, in principle, this approach enables one to 
correct for variations in the amount and/or quality of the starting template that are introduced during 
upstream phases of the workflow[20]. The simplest and most widely used model of RE is known as the  
2
-ΔΔCt
 method[21] and can be described by the following equations:  
        (1) 
     (2) 
         (3) 
where GOIS = Cq for the gene of interest (GOI) from a noncalibrator sample, ERGS = Cq for the ERG 
from a noncalibrator sample, GOIC = Cq for the GOI from a calibrator sample, and ERGC = Cq for the 
ERG from a calibrator sample. Although this model is popular due to its simplicity, it is based on a 
number of assumptions, some of which are more crucial to the inferential conclusions of a study than 
others (discussed in the next section). One of the most crucial assumptions is that the ERG being used for 
normalization is invariant across the groups being considered. Also of critical importance is that the 
reaction efficiencies are equal among the four reactions that are used to calculate RE. Finally, there must 
be a doubling of the reaction product following every cycle (i.e., a percentile reaction efficiency [PAE] of 
one or a reaction efficiency [E] of two) in order for the 2
-ΔΔCt
 method to estimate the magnitude of RE 
accurately. In practice, any combination of these assumptions can be violated, with the end result being an 
inaccurate estimate of RE and/or spurious statistical significance[8,18,22,23]. 
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ADDRESSING ASSUMPTIONS THAT ARE LIKELY TO BE VIOLATED 
Endogenous Reference Gene Stability 
Perhaps the most critical assumption of all relative expression RT-qPCR analyses is that the ERG used 
for normalization is invariant across all of the groups being considered[8,20,22,23]. It has long been 
known that assuming that highly expressed ―housekeeping‖ genes are invariant across treatments/groups 
is poor practice. Moreover, it is unlikely that any genes are universally suitable as ERGs across all tissues 
and research paradigms. Therefore, it is important to verify that ERGs are invariant each time one wishes 
to investigate a new experimental system or tissue[7,14,23,24]. However, ERG validation is often 
challenging and can become a circular problem because without a way of accounting for the effect of 
each RNA sample, it can be difficult to tell whether differences in ERG Cq values are due to differences 
among the groups being compared or to the technical variation that one is trying to remove via 
normalization[25,26,27].  
A widely used approach to ERG validation is implemented by the geNorm software package[25]. 
Here, it is assumed that candidate ERGs are not coregulated, so that pair-wise calculations between the 
candidates based on the set of RNA samples to be compared can be used to arrive at metrics of stability 
for each candidate[25]. These metrics are, in turn, used to arrive at a subset of candidate ERGs from 
which a normalization factor (NF) based on the geometric mean of the subset is calculated. However, this 
so-called pair-wise approach has been criticized by Andersen et al.[26], who put forth a model-based 
approach to ERG validation that is implemented by the NormFinder software package. The statistical 
model proposed by Andersen et al.[26] is: 
        (4) 
where yigj = the log-transformed expression measure for candidate ERG i in the jth sample of group g, αig 
= the effect of candidate ERG i within experimental group g, βgj = the effect of RNA sample j from 
experimental group g, and εigj = a random variable (error term) with a mean of zero and variance σ
2
. By 
using this model as a starting point, Andersen et al.[26] arrived at estimates of intra- and intergroup 
variation in gene expression for candidate ERGs, and derived stability values (i.e., metrics) for each 
candidate. Andersen et al.[26] compared their approach to the pair-wise approach of Vandesompele et 
al.[25], and were able to show that their model-based approach selected ERGs with low intra- and 
intergroup variation and was robust to candidate panels in which some of the candidate ERGs were 
coregulated. The pair-wise approach, on the other hand, selected sets of ERGs with correlated expression 
profiles rather than genes with low intra- and intergroup variation. Thus, in situations where the 
expression of candidate ERGs are correlated across groups/treatments, the pair-wise method of 
Vandesompele et al.[25] may select ERGs that lead to inaccurate estimates of RE[26]. 
Although the model-based approach of Andersen et al.[26] is robust with respect to candidate ERG 
panels in which some of the genes are coregulated, its validity depends on several assumptions. For 
example, the model-based approach assumes that the average expression of the candidate ERGs does not 
vary across the groups being considered. To meet this assumption, Andersen et al.[26] originally 
demonstrated the model-based approach with candidate ERGs that were carefully selected from 
microarray data that suggested that the candidates were stably expressed across the groups of interest. 
Thus, in cases where microarray data are not available for candidate ERG identification, it may be 
difficult to assess the assumptions of the model-based approach. Hence, when microarray data are not 
available ahead of time, the pair-wise method of Vandesompele et al.[25] may be more feasible, provided 
that the user is aware of its assumptions and limitations (see above).  
To conclude our discussion on ERG stability, we point out that mixed effect models provide a well-
established framework for modeling correlated data and individual effects[28]. Nevertheless, to the best 
of our knowledge, mixed models have not been used to derive statistical tests of ERG stability. However, 
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if we wish to evaluate the suitability of a candidate ERG among g groups and j RNA samples, then 
provided that there is sufficient technical replication of Cq for each of the j samples, we can formulate the 
following mixed model:  
       (5) 
where yigj = the ith Cq reading from the jth RNA sample in the gth group, β0 = the intercept, Gg = the fixed 
effect of the gth group, Ij(Gg) = the random effect of the jth RNA sample nested within the gth group, and 
εigj = the error associated with the ith Cq reading from the jth RNA sample in the gth group. Of particular 
relevance is that this model allows us to avoid circularity by enabling us to assess whether there is 
significant variation in candidate ERG Cq values among groups (i.e., test for statistical significance of the 
Gg term) in the presence of parameters that allow for the statistical removal of the effects of individual 
RNA samples. 
Estimating Reaction Efficiency 
Another assumption of the 2
-ΔΔCt
 model that is likely to be violated is the assumption of 100% reaction 
efficiency (i.e., E = 2 or PAE = 1) for all of the reactions that are used to calculate RE[18]. While it is 
unlikely that any PCR has precisely 100% efficiency, implicit to this assumption is the additional 
assumption that all of the reactions used to calculate RE have equal efficiencies. Thus, while situations in 
which E differs from two, but is more-or-less equal among the reactions used to calculate RE, will result 
in inaccurate estimates of RE, they are not likely to result in erroneous inferences about differences 
between groups. However, cases in which the efficiencies of the reactions used to calculate RE are 
qualitatively different will lead to poor estimates of RE and may lead to erroneous inferences about 
differences between groups. Thus, the assumption of equivalent efficiencies is more critical than the 
assumption of 100% reaction efficiency when it comes to determining whether there are differences 
among groups. One of the first models to incorporate the concept of reaction efficiency into the 
calculation of RE was put forward by Pfaffl[29]. According to Pfaffl[29], the relative expression ratio is: 
          (6) 
where, EGOI = the reaction efficiency of the gene of interest, EERG = the reaction efficiency of the 
endogenous reference gene, and GOIC, GOIS, ERGC, and ERGS are as defined above for Eq. 1. 
Recently, this model has been expanded by Hellemans et al.[30] to the following form that allows for 
multiple ERGs:  
         (7) 
where f = the number of ERGs used for normalization and the remaining variables are as defined for Eq. 
6. It is important to note that while these models account for differences in E between the GOI and ERG, 
they assume that neither EGOI nor EERG vary between calibrator and noncalibrator samples. As is briefly 
discussed below, this assumption may be violated, and methods for assessing whether this is the case 
have been presented by Burns et al.[31] and Yuan et al.[17,18]. 
The introduction of E into relative quantification models means that E must be empirically estimated 
in order for these models to be used. The most commonly used approach for doing this is to estimate the 
average E from a series of reactions that were set up using a variety of cDNA template concentrations 
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(i.e., a dilution series). One can then equate the slope of the linear regression of log10(cDNA 
concentration) against Cq to E as follows:  
          (8) 
where m is the slope estimated via linear regression (Fig. 2A)[8,29]. More recently, Yuan et al.[17,18] 
suggested estimating the PAE by regressing the log2(cDNA concentration) against Cq as in Fig 2B. E and 
PAE can be related by Eq. 9[18]. 
        
   (9) 
 
FIGURE 2. Various methods of estimating E and PAE. (A) Estimation of E from a dilution 
series using the log10(cDNA concentration) method. E is estimated using Eq. 8 (see text). (B) 
Estimation of PAE from the same dilution series shown in panel A using the log2(cDNA 
concentration) approach. LCL = lower 95% confidence limit of the slope and UCL = upper 95% 
confidence limit of the slope. Note that the estimate of PAE is marginally greater than 1 at the 
0.05 level, indicating that this method has overestimated the true value of PAE. (C) A log2 
transformation of the amplification plot shown in Fig. 1. The exponential phase of the reaction 
consists of cycles 18 through 22 as indicated by the dashed vertical lines. (D) Estimation of PAE 
using the exponential phase cycles highlighted in panel C. Note that the estimate of PAE is not 
significantly different from 1 at the 0.05 level. 
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The advantage of using the approach of Yuan et al.[17,18] is that the slope of the regression can be 
interpreted on the raw scale (i.e., PAE = -m, where m is the slope estimated via regression), which, in 
turn, leads to straightforward statistical tests of departures from 100% efficiency (i.e., is PAE = -1?) and 
differences among samples/groups (i.e., do the slopes estimated from different samples/groups differ from 
each other?; also see Burns et al.[31]).  
Despite being the most commonly used method, estimating E or PAE from dilution series data has 
several drawbacks. Most obviously, the dilution series method requires considerable amounts of RNA and 
is laborious. Hence, for large experiments, it may not be feasible to estimate E for every sample and gene 
combination. In addition, the dilution series approach does not estimate reaction-specific efficiencies, but 
rather the average E across several reactions. Thus, dilution series–based estimations provide no means of 
identifying reactions with outlying E values (see below). Finally, dilution series–based methods 
occasionally yield estimates of E that are >2, suggesting that they are prone to overestimating E (Fig. 
2B)[8]. 
The second general method for estimating reaction efficiencies is to use the cycle-by-cycle 
fluorescence data that are collected during the course of a real-time PCR (Fig. 1). This approach has the 
advantage of being able to yield an estimate of the reaction efficiency for every reaction. Furthermore, 
unlike the dilution series approach, it does not require additional labor as fluorescence data are acquired 
during the course of conducting an experiment. A number of strategies for estimating reaction efficiencies 
from fluorescence data have been suggested in the literature. However, the most straightforward 
approaches involve identifying the exponential phase of the amplification curve (Fig. 1; see Pierson et 
al.[32] and Ramakers et al.[33] for descriptions of algorithms that are useful for automating the process of 
identifying the exponential phase), and regressing the resulting log10[32,33] or log2[18] transformed 
subset of fluorescence values against cycle number (Fig. 2C,D). The resulting slope of this regression can 
be used to obtain an estimate of E or PAE (Fig 2D). As is the case with dilution series data, using the log2 
scale has the advantage of yielding estimates of PAE that are interpretable on the raw scale as the slope of 
the regression on the log2 scale is itself an estimate of PAE.  
While estimating reaction efficiencies from fluorescence data has several advantages over the dilution 
series method (see above), there are some drawbacks. An obvious concern is that for large experiments 
involving thousands of reactions, using florescence-based approaches creates a considerable informatics 
problem. Another concern that arises when using fluorescence-based methods that rely on linear regression 
is that the reaction efficiency estimates will be based on small sample sizes due to the exclusion of a large 
number of reaction cycles. Finally, it is not clear that using the efficiency estimates generated for every 
reaction in a dataset is the most appropriate use of this information as analyzing data based on reaction-
specific efficiencies may introduce considerable noise into a dataset[32,34]. Pierson et al.[32] and Cikos et 
al.[34] have suggested that analyses based on averaged efficiencies provide more robust results and that 
reaction-specific efficiencies should be used primarily to exclude reactions that have outlying efficiencies.  
In conclusion to our discussion of efficiency, we note that we have only reviewed strategies that use 
linear regression to estimate E or PAE from fluorescence data. Our reason for doing this is that linear 
regression is the most conceptually simple approach to estimating reaction efficiencies and is therefore 
likely to be the most accessible to practicing biologists with a limited background in statistics. Nevertheless, 
several strategies for addressing the issue of reaction efficiency that rely on nonlinear regression have also 
been proposed[35,36,37], many of which are implemented by the qpcR software package[38]. 
STATISTICAL INFERENCE 
Conventional Tests and Data Transformation 
By far the most common way in which RT-qPCR data are analyzed is via the use of standard parametric 
statistical tests (i.e., t-test, ANOVA, etc.) that assess whether RE varies as a function of the 
groups/treatments being considered. As described in the previous section, there are a number of situations 
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that can render such analyses invalid. Nevertheless, if the assumptions that are essential to calculating 
unbiased estimates of RE are met, the application of objective statistical methods to relative expression 
RT-qPCR data is valid. When using conventional parametric statistics to evaluate RT-qPCR data, it is 
important to bear in mind that RE is not symmetrically scaled as up-regulated values of RE lie on one scale 
(1 < RE < ∞) and down-regulated values lie on another scale (1 > RE > 0). We recommend analyzing 
log2(RE) because log transformations of RE result in symmetrically scaled expression measures that are 
more likely to meet the assumption of normality that is inherent to most parametric models[27]. As shown 
in Eq. 3, ΔΔCq lies on the same scale as log2(RE) and thus offers the same advantages. 
Permutation Procedures and Linear Models for Comparisons of Two Groups 
Although most analyses of relative expression RT-qPCR data use conventional parametric tests, several 
authors have suggested RT-qPCR–specific methods for drawing inferences about whether RE (or 
transformations thereof) statistically differs between two groups of interest. One of the earliest methods 
for doing this was put forward by Pfaffl et al.[39] and is based on a resampling procedure. In this 
approach, two biologically replicated groups (i.e., calibrator and noncalibrator) are considered in which 
one group consists of n1 samples and the second group consists of n2 samples. For each sample in both 
groups, GOI and ERG Cq values are generated (potentially with technical replication) and RE is calculated 
according to Eq. 6, using the means of the two respective groups (i.e., calibrator and noncalibrator) for 
GOIS, ERGS, GOIC, and ERGC. A large number of pseudosamples (>1000) are then generated by 
permutating the group labels of the GOI and ERG readings. RE is then calculated for each pseudosample 
and the proportion of pseudosamples with more extreme RE values than the observed RE value is used to 
estimate a p value for the null hypothesis that the two groups have an RE of 1 (i.e., log[RE] = 0; see Pfaffl 
et al.[39] for additional details). 
More recently, Yuan et al.[17,18] proposed a number of ways to estimate and assess the statistical 
significance of ΔΔCq using linear models. Particularly noteworthy is that Yuan et al.[18] were able to 
demonstrate the flexibility of their approach by presenting methods for estimating an efficiency-adjusted 
ΔΔCq (ΔΔCqadj; Eq. 10) based on dilution series data and fluorescence data.  
 (10)  
While a comprehensive review of the methodologies developed by Yuan et al.[17,18] for estimating 
and assessing ΔΔCq is beyond the scope of this review, we present one of the models from Yuan et al.[17] 
to give a feel for these authors’ approach to assessing statistical significance of RT-qPCR data. Here, we 
assume that a researcher wants to assess whether two biologically replicated groups (i.e., calibrator and 
noncalibrator) differ in the expression of a GOI that has been normalized to an ERG. Moreover, we 
assume that the researcher has generated dilution series data for every calibrator and noncalibrator sample 
for both the GOI and the ERG. Once in place, these data can be recoded into four groups such that group 
one corresponds to GOI readings from calibrator samples, group two corresponds to GOI readings from 
noncalibrator samples, group three corresponds to ERG readings from calibrator samples, and group four 
corresponds to ERG readings from noncalibrator samples. An analysis of covariance (ANCOVA) model 
of the following form can then be fit to the data: 
  (11)  
where β0 = the intercept, βcon = the effect of template concentration, βgroup = the effect of the grouping 
variable described above, βgroupcon = the effect of the interaction between group and concentration, and ε = 
the error term. It then follows that contrasting the parameters associated with the βgroup term (i.e., μx below 
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where x is one of the four groups described above) according to Eq. 12 results in an estimate of ΔΔCq as 
well as a test of the null hypothesis that ΔΔCq = 0. 
         (12) 
The parameters associated with the βgroupcon term are also of interest as they are slopes that describe 
how Cq changes as a function of log2(template concentration) for each of the four groups. Thus, the 
βgroupcon parameters can be used to test for equal efficiencies among groups and/or to efficiency correct 
(see Eq. 10) the ΔΔCq estimate that results from the contrast presented in Eq. 12[18]. 
While the RT-qPCR specific approaches to inference described above provide explicit statistical 
frameworks for interpreting results, they do not, in and of themselves, alleviate the burden of meeting the 
assumptions of relative expression models. Therefore, it is still critical to ensure that ERGs are invariant 
and that data comply with the assumptions about reaction efficiency made by the model. At present, a 
major drawback to many of the RT-qPCR specific statistical tests is that they only allow for comparisons 
of two groups. Thus, there is a need for general RT-qPCR–specific statistical frameworks that enable 
researchers to assess complex experimental designs, while simultaneously providing tools for inspecting 
data quality with respect to the assumptions that are critical to the validity of the method. 
DATA PROCESSING, ERROR PROPAGATION, AND RECOMMENDATIONS 
It has now been repeatedly demonstrated that the way in which RT-qPCR data are processed and analyzed 
can strongly influence the biological conclusions drawn from the data[16,40]. Although a large number of 
processing procedures have been described in the literature, there is currently no consensus on which 
methods are most robust. The quality control and processing steps that are essential to calculating valid 
RE values include baseline determination, threshold determination, control gene validation, efficiency 
estimation, and removal of reactions with outlying Cq[31] and/or E values. In addition, if samples from 
separate runs (i.e., separate microtiter plates) are to be directly compared, it is likely that some sort of 
inter-run calibration will be required[30]. One of the most important issues associated with data 
processing that is a source of ongoing research is the issue of error propagation[9,30,41]. Of particular 
concern within the context of the approaches to data analysis discussed in this review is that all of the 
components needed to calculate RE, such as efficiency estimates and Cq values, are themselves measured 
with uncertainty. Although it is common practice to technically replicate Cq values (i.e., taking the 
average of several Cq values that were generated from the same RNA sample), the dispersion estimates 
(e.g., variance, standard error, etc.) associated with technically replicated Cq values are often not used to 
calculate measures of dispersion for RE. Moreover, error propagation with respect to the uncertainty 
surrounding efficiency estimates is also frequently lacking. Thus, there is a need to develop processing 
procedures that account for this uncertainty as well as user-friendly software implementations of these 
procedures that make them readily available to practicing biologists. 
When conducting RT-qPCR experiments, one of the first decisions that must be made is which genes 
to evaluate for suitability as ERGs. In cases where companion microarray data are available, the model-
based approach of Andersen et al.[26] is well suited for ERG identification. In situations where 
companion microarray data are not available, the pair-wise approach of Vandesompele et al.[25] may 
enable the identification of ERGs that allow for the calculation of a stable NF. Irrespective of whether a 
single ERG or an NF is used for normalization, the mixed model presented in Eq. 5 can be used as a post 
hoc assessment of whether the selected ERG or NF is stable across the groups of interest after the effects 
of the individual RNA samples have been statistically removed. Once it is clear that the ERG/NF is 
indeed stable, the next step is to estimate E or PAE. In our opinion, estimating the PAE from fluorescence 
data on the log2 scale according to Yuan et al.[18] offers several advantages. First, unlike the dilution 
series method, it does not require additional labor, reagents, and RNA, which may be prohibitive if there 
are a large number of samples or GOIs to investigate. Second, linear regression on the log2 scale enables a 
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direct estimate of PAE for every reaction as well as a statistical test of whether PAE statistically differs 
from one. Third, standard methodologies for comparing the slopes of different regression models[31,42] 
can be used to assess whether any of the slopes used to calculate a given RE value statistically differ from 
one another. Therefore, one is not forced to make the assumption that EERG and EGOI are equal across the 
groups being considered (see Eqs. 6 and 7). Eq. 10 can then be used to calculate ΔΔCqadj. However, the 
PAE parameters in this equation should be based on the average PAE for each of the four respective 
groups, and reactions with outlying Cq values and/or PAE values should be excluded. In cases where there 
are more than two groups to compare, there will be more than one noncalibrator group. Because ΔΔCqadj 
lies on the log2 scale, ΔΔCqadj can itself be treated as an expression measure and analyzed using 
conventional parametric statistical tests such as ANOVA. 
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